Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.

ABSTRACT:

Background

Rhythm control strategies for atrial fibrillation (AF), including catheter ablation, are substantially underused in racial/ethnic minorities in North America.

Objectives

This study sought to describe outcomes in the CABANA trial as a function of race/ethnicity.

Methods

CABANA randomized 2,204 symptomatic participants with AF to ablation or drug therapy including rate and/or rhythm control drugs. Only participants in North America were included in the present analysis, and participants were subgrouped as racial/ethnic minority or nonminority with the use of National Institutes of Health definitions. The primary endpoint was a composite of death, disabling stroke, serious bleeding, or cardiac arrest.

Results

Of 1,280 participants enrolled in CABANA in

SUBMITTER: Thomas KL 

PROVIDER: S-EPMC8354144 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature